Johnson Financial Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Johnson Financial Group, Inc.

$2.19 Billion
Q3 2024

A detailed history of Johnson Financial Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 2,813 shares of REGN stock, worth $2.08 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,813

Previous 2,757 2.03%

Holding current value

$2.08 Million

Previous $2.9 Million 2.07%

% of portfolio

0.14%

Previous 0.14%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $57,349 - $67,298	56 Added 2.03%	2,813 $2.96 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $1.63 Million - $1.98 Million	1,844 Added 201.97%	2,757 $2.9 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $41,523 - $45,694	46 Added 5.31%	913 $878,000
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $198,446 - $225,715	-256 Reduced 22.8%	867 $761,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $142,644 - $173,940	-206 Reduced 15.5%	1,123 $924,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $118,305 - $140,329	-169 Reduced 11.28%	1,329 $954,000
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $223,881 - $272,073	329 Added 28.14%	1,498 $1.23 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $14,117 - $15,327	20 Added 1.74%	1,169 $843,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $119,959 - $151,382	-209 Reduced 15.39%	1,149 $856,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $19,740 - $26,598	36 Added 2.72%	1,358 $803,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $32,136 - $37,715	54 Added 4.26%	1,322 $923,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $61,413 - $75,819	113 Added 9.78%	1,268 $801,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $52,236 - $61,967	-91 Reduced 7.3%	1,155 $699,000
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $61,464 - $72,610	130 Added 11.65%	1,246 $696,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $21,443 - $26,313	-48 Reduced 4.12%	1,116 $528,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $17,218 - $21,887	-36 Reduced 3.0%	1,164 $562,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $119,300 - $144,147	219 Added 22.32%	1,200 $672,000
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $51,305 - $66,967	-104 Reduced 9.59%	981 $612,000
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $8,740 - $12,855	-26 Reduced 2.34%	1,085 $530,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $578,414 - $794,436	-2,110 Reduced 65.51%	1,111 $417,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $73,834 - $85,965	270 Added 9.15%	3,221 $893,000
Q2 2019 Aug 09, 2019	BUY	$299.6 - $414.82 $204,327 - $282,907	682 Added 30.06%	2,951 $923,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $130,600 - $154,289	351 Added 18.3%	2,269 $931,000
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $627,311 - $752,878	1,868 Added 3736.0%	1,918 $716,000
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $21,569 - $25,200	50	50 $22,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.

Account

Johnson Financial Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History